An open add-on study on cyclophosphamide in patients with refractory myasthenic crisis
|Updated:2026-03-12
|
An open add-on study on cyclophosphamide in patients with refractory myasthenic crisis
An open add-on study on cyclophosphamide in patients with refractory myasthenic crisis
解放军医学杂志(英文版)2003年第1期 页码:45-47
Affiliations:
1. Department of Neurology
2. Changhai Hospital
3. Second Military Medical University
4. ,China
Author bio:
Funds:
DOI:
中图分类号:R741
纸质出版:2003
Accepted:
Scan QR Code
An open add-on study on cyclophosphamide in patients with refractory myasthenic crisis[J]. 解放军医学杂志(英文版), 2003,(1):45-47.
[1]蒋建明,涂来慧,吴涛,张仁琴,丁素菊,蔡建英.An open add-on study on cyclophosphamide in patients with refractory myasthenic crisis[J].Journal of Medical Colleges of PLA,2003(01):45-47.
An open add-on study on cyclophosphamide in patients with refractory myasthenic crisis[J]. 解放军医学杂志(英文版), 2003,(1):45-47.DOI:
[1]蒋建明,涂来慧,吴涛,张仁琴,丁素菊,蔡建英.An open add-on study on cyclophosphamide in patients with refractory myasthenic crisis[J].Journal of Medical Colleges of PLA,2003(01):45-47.DOI:
An open add-on study on cyclophosphamide in patients with refractory myasthenic crisis
摘要
Abstract
<正> Objective: To assess the efficacy and side effects of cyclophosphamide on refractory myasthenic crisis. Methods: Five patients of myasthenic crisis refractory to usual comprehensive treatment
entered an open additional study with cyclophosphamide 200 mg VD q. d or 400 mg VD q. o. d with 6-10 g of total dosage. The patients were followed up for 1-8 years. Results: All the 5 patients were effectively treated with obvious remission in 3 and improvement in 2. Two patients have returned to partial work. The side effects were tolerable. Conclusion: The present clinical trial showed that cyclophosphamide was effective
particularly in a long term as an additional therapy for treating MG patients with refractory crisis of myasthenia gravis.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.